spacer
home > pmps > summer 2019 > the end of the automation pyramid
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The End of the Automation Pyramid

With structures over four thousand years old, Egypt boasts some of the oldest pyramids in existence. However, the history of automation’s pyramid, a diagram representing the integration of technologies, dwarfs in comparison. Could this engineering concept be coming to an end?

As a pictorial example of the different levels of automation in a factory, the automation pyramid has long been used as a visual aid to understand how layers of technology communicate.

Starting from process and field levels and working up to the corporate level of manufacturing processes, the traditional pyramid illustrates how devices, actuators, and sensors on the factory floor are distinctly separate from other areas such as process control, supervisory networks, and enterprise systems.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Stefan Reuther is an Industrial Engineer and holds a degree in Law and Economics from the Paris Lodron University of Salzburg, Austria. Since the beginning of 2017, he has been part of the Executive Board and Chief Sales Officer at COPA-DATA in Salzburg. He is in charge of sales and business development for the entire COPA-DATA group. His extensive experience in industrial automation, strategic management, and law helps him ensure the company meets its target growth trajectory.
spacer
Stefan Reuther
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Regulatory bottlenecks mean EU clinicians and patients could lose access to medical devices under new rules

European clinicians and their patients could lose access to vital medical devices, including in-vitro diagnostics, due to a lack of agencies able to certify products in time to comply with strict new regulations.
More info >>

White Papers

The BioPharmaSpec Approach”: Mass Spectrometry Based Host Cell Protein Identification and Quantitation

BioPharmaSpec

1. Introduction As part of the development of any biopharmaceutical product, the impurities present must be examined, minimized and where possible characterized (1). These impurities fall into two broad categories: product-related impurities (derived specifically from the drug product itself) and process-related impurities (derived from material associated with the production, processing or purification of the sample). Host cell proteins (HCPs) are process-related impurities that require specific analysis due to the multitude of naturally occurring proteins expressed in the production cell line.
More info >>

 
Industry Events

FlyPharma Europe

22-23 October 2019, Copenhagen, Denmark

The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chain. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. There will be plenty of networking opportunities, including a complimentary evening networking event, where delegates can meet and catch up with senior and executive pharma and cargo professionals – gaining strong, new industry contacts and building on existing ones.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement